BURONI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 3.692
AS - Asia 2.644
EU - Europa 2.130
SA - Sud America 411
AF - Africa 116
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 5
AN - Antartide 1
Totale 9.014
Nazione #
US - Stati Uniti d'America 3.580
CN - Cina 1.203
SG - Singapore 572
IE - Irlanda 493
BR - Brasile 312
HK - Hong Kong 305
RU - Federazione Russa 269
DE - Germania 253
VN - Vietnam 237
UA - Ucraina 213
IT - Italia 204
FI - Finlandia 199
FR - Francia 137
GB - Regno Unito 127
SE - Svezia 105
IN - India 68
CA - Canada 60
ZA - Sudafrica 57
BD - Bangladesh 52
AR - Argentina 38
JP - Giappone 32
MX - Messico 30
IQ - Iraq 26
PL - Polonia 23
JO - Giordania 22
ES - Italia 19
TR - Turchia 17
CO - Colombia 16
ID - Indonesia 16
BE - Belgio 14
EC - Ecuador 13
AU - Australia 12
LT - Lituania 12
AZ - Azerbaigian 11
CZ - Repubblica Ceca 11
EG - Egitto 11
NL - Olanda 11
AT - Austria 10
PK - Pakistan 10
UZ - Uzbekistan 10
MA - Marocco 9
NG - Nigeria 9
CL - Cile 8
PH - Filippine 7
BO - Bolivia 6
GR - Grecia 6
PY - Paraguay 6
SA - Arabia Saudita 6
TN - Tunisia 6
VE - Venezuela 6
AE - Emirati Arabi Uniti 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
KE - Kenya 5
KG - Kirghizistan 5
MU - Mauritius 5
MY - Malesia 5
NP - Nepal 5
PE - Perù 5
TH - Thailandia 5
CH - Svizzera 4
HU - Ungheria 4
IL - Israele 4
JM - Giamaica 4
PA - Panama 4
ET - Etiopia 3
NZ - Nuova Zelanda 3
SK - Slovacchia (Repubblica Slovacca) 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
CG - Congo 2
DK - Danimarca 2
DZ - Algeria 2
EU - Europa 2
IR - Iran 2
KR - Corea 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
RO - Romania 2
ZM - Zambia 2
AL - Albania 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BH - Bahrain 1
CI - Costa d'Avorio 1
GH - Ghana 1
GM - Gambi 1
GS - Georgia del Sud e Isole Sandwich Australi 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
MM - Myanmar 1
OM - Oman 1
PS - Palestinian Territory 1
Totale 9.005
Città #
Chandler 489
Dublin 485
San Jose 379
Ashburn 367
Singapore 326
Hong Kong 301
Beijing 297
Dallas 257
Jacksonville 256
Nanjing 194
Boardman 144
Los Angeles 98
Ho Chi Minh City 91
Helsinki 86
Lauterbourg 85
Princeton 80
Lawrence 75
Nanchang 68
Pavia 68
Wilmington 68
Medford 64
Ann Arbor 63
Jiaxing 63
New York 62
Munich 61
Shenyang 59
Hanoi 58
Shanghai 56
Changsha 55
Hebei 53
Johannesburg 51
Moscow 46
Hangzhou 42
Council Bluffs 40
Buffalo 39
Tianjin 33
Santa Clara 31
Tokyo 29
Milan 28
Redondo Beach 28
São Paulo 28
Frankfurt am Main 26
The Dalles 22
Woodbridge 22
Amman 21
Denver 21
Orem 21
San Francisco 21
Brooklyn 20
London 18
Turku 18
Warsaw 18
Montreal 16
Toronto 16
Houston 15
Norwalk 15
Stockholm 15
Chicago 14
Columbus 14
Da Nang 14
Boston 13
Brussels 13
Mexico City 13
Phoenix 13
Poplar 13
Verona 13
Mumbai 12
Ottawa 12
Seattle 12
Washington 12
Baku 11
Brasília 11
Falkenstein 11
Rio de Janeiro 11
Rome 11
Atlanta 10
Baghdad 10
Falls Church 10
Nuremberg 10
Olomouc 10
Tashkent 10
Fairfield 9
Haiphong 9
Hyderabad 9
Hải Dương 9
Lagos 9
Manchester 9
Piscataway 9
Porto Alegre 9
Chennai 8
Redwood City 8
Vienna 8
Des Moines 7
St Petersburg 7
Belo Horizonte 6
Can Tho 6
Curitiba 6
Florence 6
Guangzhou 6
Jakarta 6
Totale 5.937
Nome #
Benzothiazinones Are Suicide Inhibitors of Mycobacterial Decaprenylphosphoryl-β-d-ribofuranose 2'-Oxidase DprE1. 179
Antistaphylococcal activity of the ftsz inhibitor c109 165
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 163
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 159
Analyzing the role of RND efflux transporters in Burkholderia cenocepacia: a proteomic analysis. 152
Assessment of three Resistance-Nodulation-Cell Division drug efflux transporters of Burkholderia cenocepacia in intrinsic antibiotic resistance 150
A census of RND superfamily proteins in the Burkholderia genus. 149
Efflux pump genes of the resistance-nodulation-division family in Burkholderia cenocepacia genome 149
Bactericidal and Anti-Biofilm Activity of the FtsZ Inhibitor C109 against Acinetobacter baumannii 148
Benzothiazinones Kill Mycobacterium tuberculosis by Blocking Arabinan Synthesis 143
Investigating the Mechanism of Action of Diketopiperazines Inhibitors of the Burkholderia cenocepacia Quorum Sensing Synthase CepI: A Site-Directed Mutagenesis Study 142
Decaprenylphosphoryl-β-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target 141
Differential role of RND efflux pumps in antimicrobial drug resistance of sessile and planktonic Burkholderia cenocepacia cells 140
Characterization of the mechanism of resistance to BM212, a new potential antitubercular drug. 135
Bombas de eflujo como trasportadores de membrana implicados en resistencia a antibióticos en micobacterias 132
Biochemical Characterization of Glutamate Racemase-A New Candidate Drug Target against Burkholderia cenocepacia Infections 131
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 130
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 130
Identification and characterization of the cellular target for benzothiazinones, a new potential antitubercular drug class. 129
Chemical, Metabolic, and Cellular Characterization of a FtsZ Inhibitor Effective Against Burkholderia cenocepacia 129
Discovery of new diketopiperazines inhibiting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 128
Rv2466c mediates the activation of TP053 to kill replicating and non-replicating Mycobacterium tuberculosis. 127
Mycobacterium tuberculosis Phosphoribosylpyrophosphate Synthetase: Biochemical Features of a Crucial Enzyme for Mycobacterial Cell Wall Biosynthesis. 126
Phenotypic and Genotypic Characterisation of Burkholderia cenocepacia J2315 Mutants Affected in Homoserine Lactone and Diffusible Signal Factor-Based Quorum Sensing Systems Suggests Interplay between Both Types of Systems. 123
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis. 122
Molecular characterization of the burkholderia cenocepacia dcw operon and ftsz interactors as new targets for novel antimicrobial design 122
Study of the regulation of lfrA gene coding for an antibiotic efflux pump of Mycobacterium smegmatis. 120
LfrR is a repressor that regulates expression of the efflux pump LfrA in Mycobacterium smegmatis 120
Espressione, purificazione ed analisi funzionale della NAD+ sintetasi di Mycobacterium tuberculosis, un enzima essenziale 120
Mechanism of resistance to an antitubercular 2-thiopyridine derivative that is also active against Burkholderia cenocepacia. 120
Contribution of the Mycobacterium tuberculosis efflux pumps to drug resistance 119
Efflux-mediated resistance to a benzothiadiazol derivative effective against Burkholderia cenocepacia 118
Burkholderia cenocepacia infections in cystic fibrosis patients: Drug resistance and therapeutic approaches 117
Competitive fitness of essential gene knockdowns reveals a broad-spectrum antibacterial inhibitor of the cell division protein FtsZ 116
MmpL3 is the cellular target of the antitubercular pyrrole derivative BM212 115
The MmpL3 protein is responsible for resistance to BM212, a lead antitubercular drug. 113
A new promising bactericidal compound against Burkholderia cenocepacia. 113
Antimicrobial activity of six essential oils against Burkholderia cepacia complex: Insights into mechanism(s) of action 112
Studies on the identification and characterization of the cellular target of the potential antitubercular drug BM212. 111
Mycobacterium tuberculosis: drug resistance and future perspectives 110
Role in benzothiazinone resistance of nitroreductase NfnB of Mycobacterium smegmatis 109
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 108
CodY Is a Global Transcriptional Regulator Required for Virulence in Group B Streptococcus 108
Identification of the cellular target of the potential antitubercular drug BM 212 107
Deciphering the role of RND efflux transporters in Burkholderia cenocepacia. 107
AI is a viable alternative to high throughput screening: a 318-target study 106
The cell division protein FtsZ as a cellular target to hit cystic fibrosis pathogens 106
Methodological tools to study species of the genus Burkholderia 105
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 103
Characterization of the dispirotripiperazine derivative PDSTP as antibiotic adjuvant and antivirulence compound against Pseudomonas aeruginosa 103
Role of rnd efflux pumps in drug resistance of cystic fibrosis pathogens 101
Antivirulence compounds: a future direction to overcome antibiotic resistance? 100
The crystal structure of Burkholderia cenocepacia DfsA provides insights into substrate recognition and quorum sensing fatty acid biosynthesis 99
Rv3790 is the cellular target for benzothiazinones, a new promising antitubercular drug class 98
Glutamine amidotransferase activity of NAD+ synthetase from Mycobacterium tuberculosis depends on an amino-terminal nitrilase domain. 96
The Evolution of Antimicrobial Resistance in Acinetobacter baumannii and New Strategies to Fight It 91
Fighting against resistant strains: the case of benzothiazinones and dinitrobenzamides 90
Study of antibiotic efflux pumps belonging to Resistance-Nodulation-Division (RND) family in Burkholderia cenocepacia. 89
Identification of a New FtsZ Inhibitor by Virtual Screening, Mechanistic Insights, and Structure-Activity Relationship Analyses 87
Deciphering the Role of RND Efflux Transporters in Burkholderia cenocepacia. 86
Molecular basis for antibiotic resistance in the genus Burkholderia 85
Vaccines to Overcome Antibiotic Resistance: The Challenge of Burkholderia cenocepacia 85
Identification by Reverse Vaccinology of Three Virulence Factors in Burkholderia cenocepacia That May Represent Ideal Vaccine Antigens 85
The role of RND efflux transporters in intrinsic antibiotic resistance of Burkholderia cenocepacia 84
Exploring the HME and HAE1 efflux systems in the genus Burkholderia 84
Antibiotics sustainability: another issue in the fight against antimicrobial resistance. 84
Quorum sensing as antivirulence target in cystic fibrosis pathogens 81
Evaluation of fluoroquinolone resistance mechanisms in Pseudomonas aeruginosa MDR clinical isolates. 80
Recent advances to combat ESKAPE pathogens with special reference to essential oils 78
New antivirulence compounds affecting Burkholderia cenocepacia quorum sensing in vitro and in vivo. 75
Mycobacterium tuberculosis efflux pumps: an update 72
Illumina-based chemogenomic profiling of a novel compound with antimicrobial activity reveals its role as a cell division inhibitor. 72
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 71
New Antimicrobial Strategies to Treat Multi-Drug Resistant Infections Caused by Gram-Negatives in Cystic Fibrosis 70
Molecular Mechanisms of Chlorhexidine Tolerance in Burkholderia cenocepacia Biofilms. 68
THERAPEUTIC STRATEGIES TO COMBAT STAPHYLOCOCCUS AUREUS INFECTIONS IN CYSTIC FIBROSIS 66
Structural plasticity and distinct drug-binding modes of LfrR, a mycobacterial efflux pump regulator. 65
PEGylated mucus-penetrating nanocrystals for lung delivery of a new FtsZ inhibitor against Burkholderia cenocepacia infection 65
The role of RND efflux transporters in Burkholderia cenocepacia life. 63
The Effect of 2-Thiocyanatopyridine Derivative 11026103 on Burkholderia Cenocepacia: Resistance Mechanisms and Systemic Impact 63
Various evolutionary trajectories lead to loss of the tobramycin-potentiating activity of the quorum sensing inhibitor baicalin hydrate in Burkholderia cenocepacia biofilms 59
Phenylacetyl-CoA, not phenylacetic acid, attenuates CepIR-regulated virulence in Burkholderia cenocepacia 58
Subfunctionalization influences the expansion of bacterial multidrug antibiotic resistance 53
Editorial: Community series in insights into new strategies to combat biofilms, volume II 47
Lessons from Vibrio Pathogen and the Comparative Study of Vaccines Developed 45
Editorial: Insights Into New Strategies to Combat Biofilms 41
Editorial: Burkholderia spp.-transmission, pathogenesis, host-pathogen interaction, prevention and treatment 37
Editorial: Evolution of Genetic Mechanisms of Antibiotic Resistance 34
Liposomal tobramycin and ceftazidime as advanced nanocarriers against Pseudomonas aeruginosa infections 28
Synthesis, structural characterization, and biological evaluation of cinnamaldehyde–azomethine hybrids: In Vitro and In Silico approaches 27
Totale 9.192
Categoria #
all - tutte 36.602
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.602


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202113 0 0 0 0 0 0 0 0 0 0 0 13
2021/2022362 7 5 1 17 11 12 9 20 18 11 57 194
2022/20231.329 127 113 12 125 126 119 12 83 557 7 29 19
2023/2024569 62 89 19 30 40 119 26 60 5 40 46 33
2024/20251.533 23 101 44 32 64 87 116 94 384 65 196 327
2025/20263.519 301 201 406 389 498 153 617 155 334 236 156 73
Totale 9.192